Although baseline TSLP expression in the tumor microenvironment has been associated with tumor promotion [16,17,18,19,20], harnessing the potential of TSLP induction to trigger a strong CD4+ T cell response, which has been previously shown to be cancer suppressive [9,10,21], may provide a powerful therapeutic approach against lung cancer. This evidence concerns the gene TSLP and lung carcinoma.